Send in the Clones

This book is based on what relationships were between doctors, HMO's, Hospitals, medical Insurance companies and drug companies with developmental genetic research programs. I created this intrigue thriller which bears many similarities to the current Covid-19 pandemic today. It is the story of a transplant surgeon who becomes involved in a twisted plot designed to cheat the system for money inadvertently causing harm to patients.

I wrote this novel in 1995, when medical genetics was starting to bloom. It was the beginning of gene identifi cation to discover the causes of many inherited diseases. Prior to that time, there was no genetic research development to help doctors choose the appropriate drug to treat a particular disease. I developed this story about drug manufacturers, genetic research companies, doctors, and hospitals all vying for the almighty buck. I became motivated through my observation of all these entities, watching how they were only interested in money and not in helping the sick. Through the story, I brought to bear genetic realities that have since come to the forefront. The following is an excerpt from the 2016 Scientifi c American article, "20 Years after Dolly the Sheep Led the Way—Where Is Cloning Now?"

Marvin Ginsburg majored in zoology at the University of R.I. and graduated from N.Y. Medical College. He completed residency in internal medicine at Sinai Hospital Baltimore Md. as well as at UCLA Los Angeles, along with a fellowship in pulmonary medicine. He entered the private practice of medicine in 1968 and 3 years ago became involved in an administration position that he is still serving. Marvin is a co-author of two medical publications.